Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin

Photodermatology Photoimmunology and Photomedicine

Volumn 13, Issue 1-2, 1997, Pages 50-60

  Gonzalez S ^a   Pathak, M A ^a   Cuevas, J ^b   Villarrubia, V G ^c   Fitzpatrick, T B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Langerhans cells; Photoprotection; Phototoxicity; Polypodium leucotomos; Sunburn

Indexed keywords

GERALEN; METHOXSALEN; PLANT EXTRACT; SKIN PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERYTHEMA; HUMAN; HUMAN EXPERIMENT; IMMUNOREGULATION; MELANOGENESIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHOTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN PIGMENTATION; SKIN PROTECTION; SUNBURN; TOPICAL DRUG ADMINISTRATION;

POLYPODIUM LEUCOTOMOS;

EID: 0030873959     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1997.tb00108.x     Document Type: Article

References (50)

1. Pathak MA, Fitzpatrick TB. Preventive treatment of sunburn, dermatoheliosis, and skin cancer with sun-protective agents. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KE, eds. Dermatology in general medicine, 4th edn. New York: McGraw-Hill International Book Co., 1993: 1689-1716.
2. Kripke ML . Immunology and photocarcinogenesis. J Am Acad Dermatol 1986: 14: 149-155.
3. Urbach F. Photocarcinogenesis. In: Regan JD, Parrish JA, eds. The science of photomedicine. New York: Plenum. 1982: 261.
4. Villarrubia VG, González S, Cuevas J. Immunologic alterations provoked by ultaviolet radiation. Their relation with photoageing and the appearance of skin cancer. Piel (Barc) 1996: 11: 462-470.
5. Blum H. In: Photodynamic action and diseases caused by light. New York: Hafner Publishing Co., 1964.
6. Barnhill RL, Mihm Jr. MC, Fitzpatrick TB, Sober AJ. Neoplasms: malignant melanoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine, 4th edn. New York: McGrawHill International Book Co., 1993: 1078-1115.
7. Honigsmann H, Fitzpatrick TB, Pathak MA, Wolf K. Oral photochemotherapy with psoralens and UVA (PUVA): principles and practice. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. eds. Dermatology in general medicine, 4th edn. New York: McGraw-Hill International Book Co., 1993: 1728-1754.
8. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995: 32: 53-62.
9. Stern RS, Laird N, members of the Photochemotherapy Follow-up Study. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994: 73: 2759-2764.
10. Lowe NJ. Sunprotection factors: comparative techniques and selection of ultraviolet sources. In: Lowe NJ, Shaath NA, eds. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1990: 379-393.
11. Pathak MA. Topical and systemic photoprotection of human skin against solar radiation. In: Lim HW, Soter NA, eds. Clinical photomedicine. New York, Basel, Hong Kong: Marcel Dekker, Inc., 1993: 287-306.
12. Stingl LA, Sauder DN, Iijima M, Wolff K, Pehamberger H, Stingl G. Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells. J Immunol 1983: 130: 1586-1591.
13. Kim T-Y, Kripke ML, Ullrich SE. Imrnunosuppression by factors released from UV-irradiated epidermal cells: selective effects on generation of contact and delayed hypersensitivity after exposure to UVA or UVB radiation. J Invest Dermatol 1990: 94: 26-32.
14. Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992: 149: 3865-3871.
15. Baadsgaard O, Salvo B, Mannie A, Dass B, Fox DA, Cooper KD In vivo ultraviolet-exposed human epidermal cells activate T suppressor cell pathways that involve CD4+CD45RA+ suppressor-inducer cells. J Immunol 1990: 145: 2854-2861.
16. Meuniere L, Bata-Csorgo Z, Cooper KD. In human dermis. ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigenpresenting cells are concomintantly depleted. J Invest Dermatol 1995: 105: 782-788.
17. Schwarz T, Luger TA. Effect of UV irradiation on epidermal cell cytokine production. J Photochem Photobiol B 1989: 4: 1-13.
18. Gallo RL, Stazewski R, Sauder DN, Knisely TL, Granstein RD. Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation J Invest Dermatol 1991: 97: 203-309.
19. Kondo S, Kono T, Sauder DN, Mckenzie RC. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol 1993: 101: 690-694.
20. Roberts LK, Beasley DG. Commercial sunscreen lotions prevent ultraviolet-radiation-induced immune suppression of contact hypersensitivity. J Invest Dermatol 1995: 105: 339-344.
21. Mathews-Roth MM, Pathak MA, Fitzpatrick TB, Harber LC, Kass EH. Beta-carotene as a photoprotective agent in erythropoietic protoporphyria. New Engl J Med 1970: 282: 1231-1234.
22. Hipólito Ruiz. Disertaciones sobre la raìz de la rat : nhia de la calaguala y de la china y acerca de la yerba llamada cauchalagua. Imprenta Real, Madrid 1796. Cited in: Biblioteca de Clásicos de la Farmacia Espanola 1992.
23. Horvarth A, Alvarado F, Szöcs J, Ney de Alvarado Z, Padilla G. Metabolic effects of calagualine, an antitumoral saponine of Polypodium leucotomos. Nature 1967: 214. 1256-1258.
24. Vargas J, Muñoz C, Osorio C, Garcia-Olivares E. Anapsos, an antipsoriatic drug which increases the proportion of suppressor cells in human peripheral blood. Ann Immunol (Inst. Pasteur) 1983: 134C: 393-400.
25. Rayward J, Villarrubia VG, Manzano L et al. An extract of Polypodium leucotomos inhibits human T-lymphocyte proliferation in vitro. Int J Immunopharmacol (in press).
26. Tuominen M, Böhlin I, Lindbom L-O, Rolfsen W. Enhancing effect of an extract of Polypodium leucotomos on the prevention of rejection on skin transplants in mice. Phytother Res 1991. 5: 234-236.
27. Antón-Alvarez X, Franco A, Fernández-Novoa L, Cacabelos R. Effects of anapsos on behaviour and brain citokines in rats. Ann Psychiatry 1992: 3: 329-341
28. Tuominen M, Bohlin I, Rolfsen W. Effects of calaguala and an active principle, adenosine, on platelet activating factor. Planta Med 1992: 58: 306-310.
29. Corrales-Padilla H, Lainez HN, Pacheco JA. A new agent (hydrophilic fraction of Polypodium leucotomos) for management of psoriasis. Int J Dermatol 1974: 13: 276-282.
30. Jiménez D, Naranjo R, Doblaré E, Munoz C, Vargas JF. Anapsos, an antipsoriatic drug, in atopic dermatitis. Allergol Immunopathol (Madr) 1987: 15: 185-189.
31. Mohammad A. Vitiligo repigmentation with anapsos (Polypodium leucotomos) (letter). Int J Dermatol 1989: 28: 479.
32. Corrales H, Pathak MA, Fitzpatrick MA, Gonzalez S. The use of oral and topical Polypodium leucotomos (Difur®) in the treatment of vitiligo. Am Acad Dermatol 1994: Scientific Poster Exhibit 38.
33. Jaen P, Alonso ML, Martin M, Fitzpatrick TB, Pathak MA. The potential use of the fern Polypodium leucotomos in the therapy of vitiligo. American Academy of Dermatology 1994: Scientific Poster Exhibit 39.
34. Gonzalez S, Pathak MA. Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema, and skin photosensitization by Polypodium leucotomos. Photodermatol Photoimmunol Photomed 1996: 12: 45-56.
35. Sunscreen drug products for over-the-counter human drugs: proposed safety, effectiveness, and labeling conditions. Federal Register. Washington, DC, Department of Health, Education and Welfare. Food and Drug Administration, August 25, 1978: 43(166): 38206-38369.
36. Gange RW, Soparkar A, Matzinger E et al. Efficacy of a sunscreen containing butyl methoxy-dibenzoyl methane against ultraviolet A radiation in photosensitized subjects. J Am Acad Dermatol 1986: 15: 494-499.
37. Pathak MA. Topical and systemic approaches for the prevention of acute and chronic sun-induced skin reactions. Dermatol Clin 1986: 4: 321-334.
38. Lowe NJ, Dromgole SH, Septor J, Bourget T, Weingarten D. Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects. J Am Acad Dermatol 1987: 17: 224-230.
39. Krenács L, Tiszalvicz L, Krenács T, Boumsell L. Immunohistochemical detection of CD1a antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody O10 J Pathol 1993: 171: 99-104.
40. Pathak MA. Immediate and delayed pigmentary and other cutaneous responses of solar UVA radiation. In: Urbach F, Gange RW, eds. The biological effects of UVA radiation. Westport, CT: Praeger Publishers, 1986: 156-167.
41. Pathak MA, Fanselow DL. Photobiology of melanin pigmentation: dose/response of skin to sunlight and its contents. J Am Acad Dermatol 1983: 9: 724-733.
42. Kollias N, Malallah YH, Al-Ajmi H. Baqer A. Johnson B, Gonzalez S, Erythema and melanogenesis action spectra in heavily pigmented individuals as compared to fair-skinned Caucasians. Photoderm Photoimmunol Photomed 1996: 12: 183-188.
43. Gange RW, Park Y-K, Auletta M, Kagetsu N, Blackett AD, Parrish JA. Action spectra for cutaneous responses to ultraviolet radiation. In: Urbach F, Gange RW, eds. The biological effects of UVA radiation. Westport, CT, Praeger Publishers, 1986: 57-65.
44. Carraro C, Pathak MA. Studies on the nature of in vitro and in vivo photosensitization reactions by psoralens and porphyrins. J Invest Dermatol 1988: 90: 267-275.
45. Friedman PS. Dissappearance of epidermal Langerhans cells during PUVA therapy. Br J Dermatol 1981: 105: 219-221.
46. Horio T, Okamoto H. The mechanism of inhibitory effects of 8-methoxypsoralen and long-wave ultraviolet light on experimental contact sensitization. J Invest Dermatol 1982: 78: 402-405.
47. Kripke ML, Morison WL, Parrish JA. Systemic sup-pression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol 1983: 81: 87-89.
48. Horio T, Okamoto H Oxygen intermediates are involved in ultraviolet radiation-induced damage of Langerhans cells. J Invest Dermatol 1987: 88: 699-702.
49. Caux C, Liu Y-J, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995: 16: 2-4.
50. Spanish Ministry of Health. Polypodium leucotomos extract (Difur®) in the treatment of psoriasis and atopic dermatitis. Assigned Registation No 55,757. January 5, 1982.